Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manesh R Patel

Showing results (441-450 of 596) with videos related to

Pageof 60
Sort By:
Journal of the American College of Cardiology|May 19, 2021
Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD TrialRupert M Bauersachs, Michael Szarek, Marianne Brodmann, et al.
European Journal of Heart Failure|April 22, 2021
Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerationsMarat Fudim, Piotr P Ponikowski, Daniel Burkhoff, et al.
Circulation|November 13, 2023
Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A 20-Year StudyBradley J Petek, Timothy W Churchill, Nathaniel Moulson, et al.
Journal of the American Heart Association|March 26, 2013
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trialDaniel E Singer, Anne S Hellkamp, Jonathan P Piccini, et al.
Thrombosis Research|April 24, 2017
Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trialYihong Sun, Dayi Hu, Susanna Stevens, et al.
American Heart Journal|June 4, 2014
PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trialPamela S Douglas, Udo Hoffmann, Kerry L Lee, et al.
Journal of the American Heart Association|June 1, 2023
Rationale and Design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) StudyNathaniel Moulson, Bradley J Petek, Michael J Ackerman, et al.
JACC. Advances|November 21, 2024
Participant Engagement and Preference Study for Clinical Outcomes Associated With Atrial Fibrillation: The PEARL-AF StudyShelby D Reed, Josephine L Harrington, Daniel P Morin, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2020
Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID TrialMarat Fudim, Charles W Hopley, Zhen Huang, et al.
American Heart Journal|November 30, 2019
Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trialRachael Ward, Zhen Huang, Frank W Rockhold, et al.
Pageof 60

Showing results (441-450 of 596) with videos related to

Sort By:
Pageof 60
Journal of the American College of Cardiology|May 19, 2021
Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD TrialRupert M Bauersachs, Michael Szarek, Marianne Brodmann, et al.
European Journal of Heart Failure|April 22, 2021
Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerationsMarat Fudim, Piotr P Ponikowski, Daniel Burkhoff, et al.
Circulation|November 13, 2023
Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A 20-Year StudyBradley J Petek, Timothy W Churchill, Nathaniel Moulson, et al.
Journal of the American Heart Association|March 26, 2013
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trialDaniel E Singer, Anne S Hellkamp, Jonathan P Piccini, et al.
Thrombosis Research|April 24, 2017
Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trialYihong Sun, Dayi Hu, Susanna Stevens, et al.
American Heart Journal|June 4, 2014
PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trialPamela S Douglas, Udo Hoffmann, Kerry L Lee, et al.
Journal of the American Heart Association|June 1, 2023
Rationale and Design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) StudyNathaniel Moulson, Bradley J Petek, Michael J Ackerman, et al.
JACC. Advances|November 21, 2024
Participant Engagement and Preference Study for Clinical Outcomes Associated With Atrial Fibrillation: The PEARL-AF StudyShelby D Reed, Josephine L Harrington, Daniel P Morin, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2020
Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID TrialMarat Fudim, Charles W Hopley, Zhen Huang, et al.
American Heart Journal|November 30, 2019
Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trialRachael Ward, Zhen Huang, Frank W Rockhold, et al.
Pageof 60